Hamdy A. Azim
Cairo University(EG)Cairo University hospitals(EG)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Global Cancer Incidence and Screening
Most-Cited Works
- → Safety of pregnancy following breast cancer diagnosis: A meta-analysis of 14 studies(2010)269 cited
- → Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trial(2011)226 cited
- → Treatment of cancer during pregnancy with monoclonal antibodies: a real challenge(2010)90 cited
- → Biology of breast cancer during pregnancy using genomic profiling(2014)68 cited
- → Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer(2024)67 cited
- → Trastuzumab versus lapatinib: The cardiac side of the story(2009)55 cited
- → Clinicopathologic Features of Breast Cancer in Egypt—Contemporary Profile and Future Needs: A Systematic Review and Meta-Analysis(2023)54 cited
- → Targeting RANKL in breast cancer: bone metastasis and beyond(2013)48 cited
- → Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients(2017)46 cited
- → Personalized treatment in metastatic triple‐negative breast cancer: The outlook in 2020(2019)44 cited